Paul C Langley

Potentially Actionable Targets: Evidence Standards for Credible Next Generation Sequencing Technology Assessment Claims

Paul C Langley, P. Langley, 2017 .

Imaginary Worlds: The Status of Simulation Modeling in Claims for Cost-Effectiveness In Diabetes Mellitus

Paul C Langley, Taeho Greg Rhee, 2016 .

Validating Imaginary Worlds? The AdViSHE Assessment Tool

Paul C Langley, 2017 .

Recent Developments in the Health Technology Assessment Process

Paul C Langley, 2007 .

Let a Thousand Models Bloom: ICER Analytics Opens the Floodgates to Cloud Pseudoscience

Paul C Langley, 2021, Innovations in pharmacy.

Fundamental Measurement and Quality-Adjusted Life Years.

Paul C Langley, Stephen P McKenna, P. Langley, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Modeling for health care and other policy decisions: uses, roles, and validity.

Paul C Langley, 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Dreamtime: Version 5.0 of the Australian Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)

Paul C Langley, P. Langley, 2017 .

The prevalence, correlates and treatment of pain in Spain

Paul C Langley, P. Langley, J. de Andrés, 2011, Journal of medical economics.

Imaginary Worlds: The European Network for Health Technology Assessment (EUnetHTA) Recommendations for Health Economic Evaluations

Paul C Langley, P. Langley, 2016 .